Citius Pharmaceuticals, Inc.CTXR
Market cap
$10.7M
P/E ratio
| 2011/09 | 2012/09 | 2013/09 | 2015/09 | 2016/09 | 2017/09 | 2018/09 | 2019/09 | 2020/09 | 2021/09 | 2022/09 | 2023/09 | 2024/09 | |
| Stock-based compensation | - | - | - | 486,271 | 732,151 | 986,620 | 779,701 | 715,983 | 803,261 | 1 | 4 | 7 | 12 |
| Cash from operations | -20,781 | -20,324 | -20,604 | -2,385,416 | -5,900,421 | -7,971,205 | -11,318,138 | -12,437,751 | -16,930,658 | -24,250,414 | -28,361,256 | -29,060,212 | -28,201,375 |
| Capital expenditures | - | - | - | - | - | -2,126 | - | - | -1,831 | -6,938 | - | - | - |
| Cash from investing | - | - | - | - | 255,748 | -2,126 | - | - | -1,831 | -40,006,938 | - | - | -5,000,000 |
| Cash from financing | 36,493 | 56,740 | 77,209 | 2 | 5 | 11 | 17 | 11 | 23 | 120 | - | 14 | 10 |
| Free cash flow | - | - | - | - | - | - | - | - | - | - |